Scholar Commons
metadata only
State Prior Authorization Prohibitions and Buprenorphine Retention Among Privately Insured Patients
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 21 U.S.C. § 801 — Congressional findings and declarations: controlled substances#577100
- 15 U.S.C. § 6715 — Certain State affiliation laws preempted for insurance companies and affiliates#565692
- Impacts of Risk Perceptions of Secondhand Exposure to Drugs on Intent to Leave Among Transit Operators: Transit Operators' Perceived Risk of Drug Exposure.#219180
- State Marijuana Laws and the Dormant Commerce Clause#641165
- 42 U.S.C. § 2000e-16c — Coverage of previously exempt State employees#593292
Record · ID 331557
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive